Literature DB >> 33568187

Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS).

Fariborz Mansour-Ghanaei1,2,3, Farahnaz Joukar4,5, Mohammadreza Naghipour2, Soheil Hassanipour3, Sara Yeganeh1, Masood Sepehrimanesh6, Mohammad Fathalipour7.   

Abstract

OBJECTIVE: Hepatitis B (HB) and C (HC) are two severe viral infectious diseases with a deleterious impact on global health. This study aimed to evaluate the prevalence of HB and HC in the Prospective Epidemiological Research Studies of the Iranian Adults (PERSIAN) Guilan Cohort Study using immunological and molecular methods.
RESULTS: The blood samples were obtained from 10,520 enrolled participants. Complete biochemical and hematological tests, as well as urine analysis, were assessed. The presence of HBsAg, anti-HBs, anti-HBc, and anti-HCV antibodies for all participant and HBeAg and anti-HBe antibodies for HB-positive patients were evaluated. Moreover, HB genomic DNA and HC genomic RNA were extracted from serum samples of HB-positive patients. The real-time PCR assay was employed to quantify the gene copies of hepatitis B and C viruses. HC genotyping was also performed. The prevalence of HB and HC was 0.24% (95% CI 0.16-0.35) and 0.11% (95% CI 0.06-0.19), respectively. Rural participants were significantly more HB-positive than the urban people (P = 0.045), while males were significantly more HC-positive than the females (P = 0.013). The prevalence of HB and HC in this area were lower than those of other geographical locations of Iran, which may be due to different lifestyles or other unknown reasons.

Entities:  

Keywords:  Hepatitis B; Hepatitis C; Iran; PERSIAN cohort; Prevalence

Mesh:

Substances:

Year:  2021        PMID: 33568187      PMCID: PMC7877021          DOI: 10.1186/s13104-021-05474-2

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  41 in total

Review 1.  Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis.

Authors:  Robera Olana Fite; Wesam Kooti; Gedion Asnake Azeze; Bekele Tesfaye; Shemsu Nuriye Hagisso
Journal:  Arch Virol       Date:  2020-03-26       Impact factor: 2.574

Review 2.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

3.  Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy.

Authors:  Tindaro Lembo; Francesca Saffioti; Benito Chiofalo; Roberta Granese; Roberto Filomia; Roberta Grasso; Onofrio Triolo; Giovanni Raimondo
Journal:  Dig Liver Dis       Date:  2017-08-01       Impact factor: 4.088

4.  High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection.

Authors:  Tahereh Donyavi; Farah Bokharaei-Salim; Khadijeh Khanaliha; Maryam Sheikh; Mohammad-Navid Bastani; Najmeh Moradi; Roghayeh Babaei; Zahra Habib; Atousa Fakhim; Maryam Esghaei
Journal:  Arch Virol       Date:  2019-07-25       Impact factor: 2.574

Review 5.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

6.  Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).

Authors:  Fariborz Mansour-Ghanaei; Mohammad S Fallah; Afshin Shafaghi; Mahmood Yousefi-Mashhoor; Naghi Ramezani; Farshid Farzaneh; Reza Nassiri
Journal:  Med Sci Monit       Date:  2002-12

7.  Prevalence of Hepatitis B and C virus infection and their co-relation with hematological and hepatic parameters in subjects undergoing Premarital Screening in the Jazan Region, Kingdom of Saudi Arabia.

Authors:  Saleh Mohammed Abdullah
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

8.  Economic Burden of Hepatitis C Virus Infection in Different Stages of Disease: A Report From Southern Iran.

Authors:  Fatemeh Zare; Mohammad Reza Fattahi; Masood Sepehrimanesh; Ali Reza Safarpour
Journal:  Hepat Mon       Date:  2016-03-05       Impact factor: 0.660

9.  Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.

Authors:  Ghada El Sagheer; Elwy Soliman; Asmaa Ahmad; Lamiaa Hamdy
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.657

10.  The Prevalence and Trends of Hepatitis B, Hepatitis C, and HIV among Voluntary Blood Donors in Kohgiluyeh and Boyer-Ahmad Transfusion Center, Southwestern Iran.

Authors:  Seyed Mehdi Sajjadi; Ali Akbar Pourfathollah; Saeed Mohammadi; Bijan Nouri; Rostam Hassanzadeh; Fariba Rad
Journal:  Iran J Public Health       Date:  2018-07       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.